MetaCap

Cardiff Oncology Insider Trades

NASDAQ: CRDFHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.08+0.02 (+1.89%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
4 · $1.12M
Sales
0 · $0
Shares bought / sold
776.35K / 0
Net activity
Net buying $1.1 million

Cardiff Oncology insider activity

Over the last 12 months, Cardiff Oncology insiders reported 4 transactions on SEC Form 4: 4 open-market purchases and 0 sales. Insiders bought $1.1 million and sold $0 worth of stock, for net insider buying of $1.1 million. The most recent filing shows PACE GARY W (Director) buying 687,285 shares at $1.46 on Jul 14, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CRDF's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CRDF insider transactions

Cardiff Oncology insider transactions
DateInsiderTypeSharesValueFiling
Jul 14, 2026Mohindru ManiChief Executive OfficerBuy34,364$50.00KForm 4
Jul 14, 2026PACE GARY WDirectorBuy687,285$1000.00KForm 4
Jun 18, 2026PACE GARY WDirectorBuy30,000$36.60KForm 4
Jun 18, 2026Mohindru ManiChief Executive OfficerBuy24,703$29.89KForm 4
Jul 30, 2025PACE GARY WDirectorBuy15,000$36.75KForm 4
Jul 30, 2025PACE GARY WDirectorBuy275,000$673.75KForm 4
Dec 18, 2024Levine James E.Chief Financial OfficerBuy2,400$12.00KForm 4
Dec 17, 2024Levine James E.Chief Financial OfficerBuy2,752$14.91KForm 4
Dec 16, 2024Levine James E.Chief Financial OfficerBuy2,564$9.82KForm 4
Dec 12, 2024TANNENBAUM RENEE PDirectorBuy10,000$34.22KForm 4
Dec 11, 2024PACE GARY WDirectorBuy11,500$29.90KForm 4
Dec 11, 2024PACE GARY WDirectorBuy350,115$910.30KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related